Somnus to Broadcast First Quarter Conference Call April 27

Apr 25, 2001, 01:00 ET from Somnus Medical Technologies, Inc.

    SUNNYVALE, Calif., April 25 /PRNewswire/ --
 Somnus Medical Technologies, Inc. (Nasdaq:   SOMN) announced today that
 investors are invited to listen to its first quarter conference call on April
 27 at 11:00 a.m. EDT at www.streetevents.com and at the Company's website
 located on www.somnus.com .  A telephonic replay of the conference call can be
 accessed for 24 hours by dialing 888-258-7854 passcode 06330.  A webcast of
 the conference call will be available on the Somnus website and for one month
 on the StreetEvents website.
 
     About the Somnoplasty System and Its Applications
     Somnus is pioneering a new standard of care for the treatment of upper
 airway disorders. The Company's proprietary Somnoplasty System is the only
 temperature-controlled radiofrequency-based technology that has been
 previously cleared by the FDA for use in the treatment of chronic nasal
 obstruction and sleep disordered breathing-obstructive sleep apnea syndrome,
 upper airway resistance syndrome, habitual snoring, as well as a device for
 tissue coagulation in the head and neck. The Somnoplasty procedures work by
 heating a targeted area of obstructive tissue below the surface. The body
 naturally resorbs the heated area over a period of three to eight weeks
 reducing tissue volume. Clinical evaluations are underway to further expand
 the indications for the treatment of other upper airway obstructions.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X16816348
 
 

SOURCE Somnus Medical Technologies, Inc.
    SUNNYVALE, Calif., April 25 /PRNewswire/ --
 Somnus Medical Technologies, Inc. (Nasdaq:   SOMN) announced today that
 investors are invited to listen to its first quarter conference call on April
 27 at 11:00 a.m. EDT at www.streetevents.com and at the Company's website
 located on www.somnus.com .  A telephonic replay of the conference call can be
 accessed for 24 hours by dialing 888-258-7854 passcode 06330.  A webcast of
 the conference call will be available on the Somnus website and for one month
 on the StreetEvents website.
 
     About the Somnoplasty System and Its Applications
     Somnus is pioneering a new standard of care for the treatment of upper
 airway disorders. The Company's proprietary Somnoplasty System is the only
 temperature-controlled radiofrequency-based technology that has been
 previously cleared by the FDA for use in the treatment of chronic nasal
 obstruction and sleep disordered breathing-obstructive sleep apnea syndrome,
 upper airway resistance syndrome, habitual snoring, as well as a device for
 tissue coagulation in the head and neck. The Somnoplasty procedures work by
 heating a targeted area of obstructive tissue below the surface. The body
 naturally resorbs the heated area over a period of three to eight weeks
 reducing tissue volume. Clinical evaluations are underway to further expand
 the indications for the treatment of other upper airway obstructions.
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X16816348
 
 SOURCE  Somnus Medical Technologies, Inc.

RELATED LINKS

http://www.somnus.com